澳股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

CLINUVEL PHARMACEUTICALS LTD

8.050

+0.1101.39%

成交量：14.93万

成交额：118.40万

市值：4.06亿

市盈率：12.05

高：8.050

开：7.950

低：7.830

收：7.940

52周最高：13.399

52周最低：7.800

股本：5,048.71万

流通股本：4,131.90万

量比：1.75

换手率：0.36%

股息：0.05

股息率：0.62%

每股收益(TTM):0.668

每股收益(LYR):0.668

净资产收益率：13.21%

总资产收益率：8.94%

市净率：1.49

市盈率(LYR):12.05

数据加载中...

总览公司新闻资讯公告

概念

医药生物股+0.66%

资金流向

资金流入：

资金流出：

新闻资讯

Clinuvel Pharmaceuticals股东将获得纳斯达克上市公司的同等经济利益

Clinuvel Pharmaceuticals 宣布战略重组，重心转向美国市场

CLINUVEL PHARMACEUTICALS LTD 宣布将公司总部迁至美国，自2027年1月1日起生效

Clinuvel Pharmaceuticals 将运营资源聚焦于美国药品研发管线与战略

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/hans/stock/CUV.AU"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CUV.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"CUV.AU\",,,,,undefined,":{"symbol":"CUV.AU","market":"AU","secType":"STK","nameCN":"CLINUVEL PHARMACEUTICALS LTD","latestPrice":8.05,"timestamp":1791781920000,"preClose":7.94,"halted":0,"volume":149329,"delay":0,"changeRate":0.013853904282115909,"nameEN":"CLINUVEL PHARMACEUTICALS LTD","floatShares":41318955,"shares":50487126,"eps":0.667999,"marketStatus":"未开盘","change":0.11,"latestTime":"10-12 16:12:00 AEDT","open":7.95,"high":8.05,"low":7.83,"amount":1183973,"amplitude":0.027708,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.667999,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":0,"beginTime":1791846000000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":7.94,"dividendRate":0.006211,"openAndCloseTimeList":[[1791759600000,1791781200000]],"volumeRatio":1.749792013334447,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"CUV.AU","preClose":7.94,"auctionPrice":8.05,"auctionVolume":9343,"auction":3,"marketStatus":"盘后竞价","timestamp":1791781814033}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"CUV.AU\",,,,,undefined,":{"symbol":"CUV.AU","floatShares":41318955,"roa":"8.94%","roe":"13.21%","lyrEps":0.667999,"volumeRatio":1.749792013334447,"shares":50487126,"dividePrice":0.05,"high":8.05,"amplitude":0.027708,"preClose":7.94,"low":7.83,"week52Low":7.8,"pbRate":"1.49","psRate":"4.32","week52High":13.399,"institutionHeld":0,"latestPrice":8.05,"eps":0.667999,"divideRate":0.006211,"volume":149329,"delay":0,"ttmEps":0.667999,"open":7.95,"prevYearClose":12.385,"prevWeekClose":7.94,"prevMonthClose":8.6,"prevQuarterClose":8.6,"fiveDayClose":8.16,"twentyDayClose":8.31,"sixtyDayClose":10.179,"dividendPayoutRate":0.07372445631899688,"dividendFrequency":"A","dividendGrowthYears":6,"dividendGrowthRate":0,"fiveYearAvgDividendRate":0.0033959070154716284},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CUV.AU\",params:#limit:5,,,undefined,":[{"date":"2026-09-03","symbol":"CUV.AU","amount":0.05,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2026-09-04","defaultRemindTime":1788393600000,"name":"CLINUVEL PHARMACEUTICALS LTD","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-18","payableDate":"2026-09-04","currency":"AUD","dateTimestamp":1788357600000,"payDate":"2026-09-18"},{"date":"2026-08-27","symbol":"CUV.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787788800000,"name":null,"time":"","dateTimestamp":1787752800000,"actualEps":null},{"date":"2026-02-26","symbol":"CUV.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1772060400000,"name":null,"time":"","dateTimestamp":1772024400000,"actualEps":null},{"date":"2025-09-04","symbol":"CUV.AU","amount":0.05,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2025-09-05","defaultRemindTime":1756944000000,"name":"CLINUVEL PHARMACEUTICALS LTD","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-19","payableDate":"2025-09-05","currency":"AUD","dateTimestamp":1756908000000,"payDate":"2025-09-19"},{"date":"2025-08-28","symbol":"CUV.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756339200000,"name":null,"time":"","dateTimestamp":1756303200000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CUV.AU\",market:\"AU\",,,undefined,":[{"executeDate":"2020-09-03","recordDate":"2020-09-04","paymentDate":"2020-09-18","value":0.025,"currency":"AUD"},{"executeDate":"2021-09-02","recordDate":"2021-09-03","paymentDate":"2021-09-17","value":0.025,"currency":"AUD"},{"executeDate":"2022-09-06","recordDate":"2022-09-07","paymentDate":"2022-09-21","value":0.04,"currency":"AUD"},{"executeDate":"2023-09-05","recordDate":"2023-09-06","paymentDate":"2023-09-20","value":0.05,"currency":"AUD"},{"executeDate":"2024-09-05","recordDate":"2024-09-06","paymentDate":"2024-09-20","value":0.05,"currency":"AUD"}],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CUV.AU\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1113829170","title":"Clinuvel Pharmaceuticals股东将获得纳斯达克上市公司的同等经济利益","url":"https://stock-news.laohu8.com/highlight/detail?id=1113829170","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1113829170?lang=zh_cn&edition=fundamental","pubTime":"2026-08-27 10:34","pubTimestamp":1787798048,"startTime":"0","endTime":"0","summary":"Clinuvel Pharmaceuticals——这家制药企业的股东们，即将迎来一项重大利好：他们将获得与纳斯达克上市公司等同的经济权益。\n这一举措意味着，持有该公司股票的投资者，将在另一家在纳斯达克挂牌交易的公司中，享有相应的经济利益份额。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CUV.AU","BK7067","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1174389314","title":"Clinuvel Pharmaceuticals 宣布战略重组，重心转向美国市场","url":"https://stock-news.laohu8.com/highlight/detail?id=1174389314","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1174389314?lang=zh_cn&edition=fundamental","pubTime":"2026-07-23 09:48","pubTimestamp":1784771302,"startTime":"0","endTime":"0","summary":"CLINUVEL PHARMACEUTICALS LTD宣布了一项重大战略重组计划，旨在将业务重心重新聚焦于美国市场。作为该计划的关键举措，公司企业总部将于2027年1月1日正式迁至美国。\n此次重组将涉及全球范围内的运营调整。公司计划削减10%至20%的全球员工，并将相关职能转移至美国本土。此举旨在集中运营资源，全力支持其在美国的药品研发管线与核心战略的推进。\n通过这次战略转移与重组，Clinuvel Pharmaceuticals 期望能够更深入地接入美国庞大的资本池，为公司未来的研发与扩张提供更强劲的资金支持。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CUV.AU","BK7067","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1129418105","title":"CLINUVEL PHARMACEUTICALS LTD 宣布将公司总部迁至美国，自2027年1月1日起生效","url":"https://stock-news.laohu8.com/highlight/detail?id=1129418105","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1129418105?lang=zh_cn&edition=fundamental","pubTime":"2026-07-23 07:12","pubTimestamp":1784761934,"startTime":"0","endTime":"0","summary":"CLINUVEL PHARMACEUTICALS LTD 已正式宣布，其公司总部将迁往美国。这一重大战略举措预计将于2027年1月1日正式生效。此举标志着公司全球运营布局进入新阶段，旨在更贴近关键市场，优化资源配置，并把握未来增长机遇。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","CUV.AU","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1138092619","title":"Clinuvel Pharmaceuticals 将运营资源聚焦于美国药品研发管线与战略","url":"https://stock-news.laohu8.com/highlight/detail?id=1138092619","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1138092619?lang=zh_cn&edition=fundamental","pubTime":"2026-07-23 07:12","pubTimestamp":1784761930,"startTime":"0","endTime":"0","summary":"Clinuvel Pharmaceuticals 宣布，将集中其运营资源，以专注于推进其在美国市场的药品研发管线与整体战略布局。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","BK7067","CUV.AU"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":2,"pageCount":1,"totalSize":8,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/CUV.AU\",params:#limit:6,delay:true,,,undefined,":[{"market":"AU","name":"医药生物股","id":"package_au_concept_yyswg","bkCode":"BK7508","changeRate":0.006583}]}}